Linked Life Data

21284701

Source:http://linkedlifedata.com/resource/pubmed/id/21284701

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
2011-2-2
pubmed:abstractText
To predict the concentration and target inhibition profiles of the survivin inhibitor antisense oligonucleotide LY2181308 in humans.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
1365-2125
pubmed:author
pubmed:copyrightInfo
© 2011 The Authors. British Journal of Clinical Pharmacology © 2011 The British Pharmacological Society.
pubmed:issnType
Electronic
pubmed:volume
71
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
416-28
pubmed:meshHeading
pubmed:year
2011
pubmed:articleTitle
Integrated analysis of preclinical data to support the design of the first in man study of LY2181308, a second generation antisense oligonucleotide.
pubmed:affiliation
Eli Lilly and Company, 13 rue Pages, Suresnes, 92158 France Eli Lilly and Company, Erlwood Manor, Sunninghill Road, Windlesham, GU20 6PH, UK. Callies_sophie@lilly.com
pubmed:publicationType
Journal Article